Abstract
BackgroundMethotrexate (MTX) is the cornerstone in the pharmacological treatment of rheumatoid arthritis (RA) patients. However, medication adherence to MTX is not ideal, which might lead to suboptimal treatment outcomes. Consequently...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
